Dr. Joanna Yi Wang, MD

Dr. Wang practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania.

Dr. Wang's NPI, 1134468705, was assigned on February 2, 2013. Dr. Wang graduated from Johns Hopkins University School of Medicine in 2016. Dr. Wang holds Pennsylvania license MD474078.

Dr. Wang's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 349-5150.

Dr. Wang's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. Dr. Wang is also affiliated with Inova Fairfax Hospital. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Wang to 4 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wang practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Wang's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Wang is licensed in Pennsylvania.

CMS data shows 140 Medicare services from Dr. Wang across 3 procedure codes in 2024, for 50 Medicare patients. Medicare paid $14,846 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 50 Medicare patients who saw Dr. Wang in 2024. The largest group is 65 to 74, with 30 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wang's median patient age at 58, with 59% women.

In 2024, Dr. Wang wrote 49 Medicare Part D claims for 17 patients. 49% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $523 in total drug cost. In 2022, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Wang for performance year 2024, reported as part of a group. Dr. Wang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wang as offering telehealth.

CMS Open Payments shows 8 general payments to Dr. Wang from 6 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Stryker Corporation paid the most, $116.

Dr. Wang graduated from Johns Hopkins University School of Medicine in 2016.